Stock Evaluator: Autonomix Medical, Inc. (AMIX)
Autonomix Medical, Inc. AMIX
$2.74
-0.11
-3.69%
October 19, 2026 12:39:29 PM
EST
Volume: 23,020
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company’s technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Financial Summary
| Share Statistics | AMIX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $5.6 | $382.9 | 4% |
|
| Shares Out (Mil) | 0.5 | 40.9 | 3% |
|
| Institutional Ownership | 35.7% | 83.6% | 15% |
|
| Float (Mil) | 1.9 | 35.5 | 5% |
|
| Beta | -0.99 | 0.86 | 1% |
|
| Avg Daily Volume (000s) | 57 | 301 | 30% |
|
| Price Change (52-week) |
(88.0%) | 61.8% | 6% |
|
| Growth | AMIX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | na | (5.5%) | na |
|
| EPS (5yr) | na | 10.6% | na |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | na | (15.5%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | AMIX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $141 | na |
|
| Net Income (TTM) (Mil) | ($16) | ($9) | 26% |
|
| EPS (TTM) | ($36.372) | ($0.400) | 2% |
|
| Operating Cash Flow (TTM) (Mil) | ($13) | ($2) | 18% |
|
| Net Cash Flow (TTM) (Mil) | na | $1 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $27 | 0% |
|
| Enterprise Value (Q1) (Mil) | $1 | $418 | 4% |
|
| Valuation | AMIX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.49 | 2.50 | 10% |
|
| P/E | na | 25.8 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.4 | na |
|
| Ratios | AMIX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 58.7% | na |
|
| Net Margin | na | (6.9%) | na |
|
| ROA | (248.2%) | (12.2%) | 1% |
|
| ROE | (316.0%) | (10.7%) | 3% |
|
| Liabilities to Assets | 20.6% | 47.2% | 13% |
|
| F-Score | 2 | 4 | 7% |
|
Autonomix Medical, Inc. did not pass any screens on 10/16/2026.
